Table 4.

Answers to PAD questionnaire applied to investigators expressed as n(%) (n = 53)

In which age group (years) of your patients do you consider to measure ABI in your clinic?
	55-59	60-64	65-69	70-74	75-79	≥80
For male patients	40 (75.5)	29 (54.7)	31 (58.5)	21 (39.6)	20 (37.7)	17 (32.1)
For female patients	31 (58.5)	31 (58.5)	32 (60.4)	21 (39.6)	20 (37.7)	17 (32.1)
Do you evaluate obese patients by physical examination and ABI with the suspect of PAD?
Yes	24(45.3)
Do you evaluate diabetic patients by physical examination and ABI with the suspect of PAD
Yes	35(66.0)
Do you evaluate smokers by physical examination and ABI with the suspect of PAD?
Yes	33(62.5)
What are the objectives of PAD treatment according to Turkish Society of Cardiovascular Surgery?
To control symptoms	39(73.6)
To prevent amputation	45(84.9)
To increase survival	46(86.8)
Do "patient history" and "physical examination" show that your patient has PAD?
Yes	12(22.6)
What should be the option(s) of your patient for the further investigation of PAD?
ABI + Doppler	50(94.3)
Cardiovascular surgery consultation	16(30.2)
Nothing, routine follow up	3(5.7)
What are the treatments of choice for ischemic events?
	Continue		Add		Stop	Contraindicate
ASA	48(92.5)		16(30.2)		0(0.0)	0(0.0)
Clopidogrel	30(56.6)		28(52.8)		0(0.0)	0(0.0)
Cilostazole	9(17)		12(22.6)		0(0.0)	0(0.0)
Statins	41(77.4)		24(45.3)		0(0.0)	0(0.0)
Other lipid lowering drugs	26(49.1)		22(41.5)		1(1.9)	0(0.0)
ACE inhibitors	38(71.7)		21(39.6		0(0.0)	0(0.0)
Other antihypertensives	24(45.3)		24(45.3)		3(5.7)	1(1.9)
Warfarin	23(43.4)		21(39.6)		3(5.7)	0(0.0)
Antihyperglycemic drug	40(75.5)		17(32.1)		0(0.0)	0(0.0)
Stop smoking program	45(85.9)		20(37.7)		1(1.9)	1(1.9)
Walking-exercise prog.	43(81.1)		23(43.4)		1(1.9)	0(0.0)